Stone Medicine Group announced that after the sale of Hin King's shareholding ratio dropped to 41.78%

Abstract: Stone Pharmaceutical Group May 27 issued a notice, the company's main shareholder Hin King Limited to a share of HK $6.25 for sale of 706 million shares, reducing the amount of cash amounted to a total of HK $4.4 billion, Hin King for Lenovo Holding company. Stone Medicine Group yesterday closed at HK $6.11
Stone Pharmaceutical Group May 27 issued a notice, the company's main shareholder Hin King Limited to a share of HK $6.25 for sale of 706 million shares, reducing the amount of cash amounted to a total of HK $4.4 billion, Hin King for Lenovo Holding company. Stone Medicine Group yesterday reported a decrease of HK $6.11 to 2.71%.

Stone Medicine Group announced that after the sale, Hin King's shareholding ratio dropped to 41.78%. Hin King is a wholly-owned subsidiary of the Selection Co., Ltd., through the selection of 4 wholly-owned subsidiaries including Yan Jing, with a 74.2% equity stake in the Stone pharmaceutical group, after the reduction of Hin King, the proportion of the selected shares dropped to 62.26%. It is a subsidiary of Hong Yi Investment by Lenovo Holdings.

In fact, the choice of the stone Pharmaceutical group's reduction and overweight has occurred many times. Last October, the company sold a total of HK $4.05 per share to the 500 million shares of the stone pharmaceutical group.